{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:03Z","timestamp":1792089963027,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bja.2021.05.027","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T09:04:29Z","timestamp":1625735069000},"page":"415-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":195,"title":["Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment"],"prefix":"10.1016","volume":"127","author":[{"given":"Thomas","family":"St\u00f6hr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Ossig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Pesic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Borkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Winkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M.R.F.","family":"Struys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schippers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2021.05.027_bib1","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.19881","article-title":"Anesthesia for patients with liver disease","volume":"14","author":"Rahimzadeh","year":"2014","journal-title":"Hepat Mon"},{"key":"10.1016\/j.bja.2021.05.027_bib2","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1053\/j.jvca.2017.04.019","article-title":"Perioperative management of patients with end-stage renal disease","volume":"31","author":"Kanda","year":"2017","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2021.05.027_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bja.2021.03.028","article-title":"Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative review","author":"Sneyd","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2021.05.027_bib4","first-page":"1735","article-title":"Emerging approaches in intravenous moderate and deep sedation","volume":"10","author":"Goudra","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.bja.2021.05.027_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4103\/1658-354X.136627","article-title":"Remimazolam: the future of its sedative potential","volume":"8","author":"Goudra","year":"2014","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.bja.2021.05.027_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/PRA.0000000000000114","article-title":"A\u00a0way of conceptualizing benzodiazepines to guide clinical use","volume":"21","author":"Preskorn","year":"2015","journal-title":"J\u00a0Psychiatr Pract"},{"key":"10.1016\/j.bja.2021.05.027_bib7","series-title":"Guidance for industry: pharmacokinetics in patients with impaired renal function, draft guidance","year":"2010"},{"key":"10.1016\/j.bja.2021.05.027_bib8","series-title":"Guidance for industry: pharmacokinetics in subjects with impaired hepatic function: study design, data analysis, and impact on dosing and labeling","year":"2003"},{"key":"10.1016\/j.bja.2021.05.027_bib9","series-title":"Declaration of Helsinki (18th WMA general assembly 1964), revised at 64th world medical association general assembly","year":"2013"},{"key":"10.1016\/j.bja.2021.05.027_bib10","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child","year":"1964","journal-title":"Major Probl Clin Surg"},{"key":"10.1016\/j.bja.2021.05.027_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-008-9094-4","article-title":"Likelihood based approaches to handling data below the quantification limit using NONMEM VI","volume":"35","author":"Ahn","year":"2008","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.bja.2021.05.027_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1213\/ANE.0b013e318241f68a","article-title":"A\u00a0placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation","volume":"115","author":"Wiltshire","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2021.05.027_bib13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1213\/ANE.0000000000000814","article-title":"A\u00a0recirculatory model for pharmacokinetics and the effects on bispectral index after intravenous infusion of the sedative and anesthetic AZD3043 in healthy volunteers","volume":"121","author":"Bj\u00f6rnsson","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2021.05.027_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-3565(24)37212-X","article-title":"Relevance of arteriovenous concentration differences in pharmacokinetic\u2013pharmacodynamic modeling of midazolam","volume":"284","author":"Tuk","year":"1998","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.bja.2021.05.027_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.bja.2021.05.027_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/psp4.12161","article-title":"Model evaluation of continuous data pharmacometric models: metrics and graphics","volume":"6","author":"Nguyen","year":"2017","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.bja.2021.05.027_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J"},{"key":"10.1016\/j.bja.2021.05.027_bib18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cts.12875","article-title":"Population pharmacokinetics of remimazolam in procedural sedation with nonhomogeneously mixed arterial and venous concentrations","volume":"14","author":"Zhou","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.bja.2021.05.027_bib19","first-page":"335","article-title":"Midazolam and other benzodiazepines","volume":"vol. 182","author":"Olkkola","year":"2008"},{"key":"10.1016\/j.bja.2021.05.027_bib20","first-page":"149","article-title":"The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients","volume":"42","author":"Driessen","year":"1991","journal-title":"Acta Anaesthesiol Belg"},{"key":"10.1016\/j.bja.2021.05.027_bib21","series-title":"Summary of product characteristics: midazolam 5 mg\/ml, solution for injection\/infusion","year":"2019"},{"key":"10.1016\/j.bja.2021.05.027_bib22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/0310057X0203000506","article-title":"Evaluation of induction doses of propofol: comparison between endstage renal disease and normal renal function patients","volume":"30","author":"Goyal","year":"2002","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2021.05.027_bib23","first-page":"15","article-title":"Anaesthesia for patients with liver disease","volume":"10","author":"Vaja","year":"2009","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"10.1016\/j.bja.2021.05.027_bib24","series-title":"StatPearls","article-title":"Use of the Child Pugh score in liver disease","author":"Tsoris","year":"2021"},{"key":"10.1016\/j.bja.2021.05.027_bib25","series-title":"On the evaluation of the pharmacokinetics of medicinal products in patients with impaired hepatic function","author":"Guideline","year":"2005"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091221003469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091221003469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:15:03Z","timestamp":1762103703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091221003469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0007091221003469"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2021.05.027","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740463280.793588218","asserted-by":"object"}]},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2021.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}